TARA Biosystems Biowire™ II Heart-on-a-Chip Platform Published in CELL
January 24, 2019
News
NEW YORK, N.Y. (Newswire.com)—January 24, 2019—TARA Biosystems, Inc., a company offering physiologically relevant human “heart-on-a-chip” tissue models for cardiac risk assessment and drug discovery applications, today announced the first peer-reviewed publication of its Biowire™ II platform by …
TARA Biosystems and Insilico Medicine Announce Drug Discovery Collaboration for Cardiac Disease
January 7, 2019
Featured
New York – TARA Biosystems, Inc. a company offering “heart-on-a-chip” tissue models for drug discovery and risk assessment applications and Insilico Medicine, an artificial intelligence company developing end-to-end drug discovery pipelines for age-related diseases, announced today the launch of a collaboration to discover and develop novel therapies for …
TARA CEO Misti Ushio Named to Fast Company's 100 Most Creative People in Business
May 30, 2018
Press Releases
New York, (Newswire.com) - TARA Biosystems is proud to announce that TARA CEO Dr. Misti Ushio has been recognized by Fast Company as one of the Top 100 Most Creative People in Business today. The annual list honors an …
TARA Appoints Donna See as Chief Business Officer
May 16, 2018
Press Releases
New York, (Newswire.com) – TARA Biosystems, Inc., a company offering physiologically human relevant “heart-on-a-chip” tissue models for drug discovery and development applications, announced the appointment of Donna See as Chief Business Officer. In this newly created role, Donna will …
TARA Appoints John M. Baldoni, Ph.D., to its Board of Directors
February 20, 2018
Press Releases
NEW YORK, (Newswire.com) - TARA Biosystems, Inc., a company offering physiologically relevant “heart-on-a-chip” tissue models for drug discovery and development applications, announced today that it has appointed pharmaceutical industry innovation leader, John M. Baldoni, Ph.D. to its Board of Directors.
TARA Biosystems offers bioanalytical testing …
TARA Appoints Michael P. Graziano as Chief Scientific Officer
August 22, 2017
Press Releases
August 22, 2017. NEW YORK, (Newswire.com) -
TARA Biosystems, Inc., a company developing physiologically relevant "heart-on-a-chip" tissue models for both toxicology and drug discovery applications, announced today that it has appointed pharmaceutical industry leader, Michael P. Graziano, Ph.D., as its Chief Scientific Officer.
TARA Biosystems offers …
TARA Biosystems Appoints Robert Langer to Board of Directors
June 22, 2016
News
June 22, 2016. NEW YORK--(BUSINESS WIRE)--TARA Biosystems, Inc., a company developing physiologically relevant “heart-on-a-chip” tissue models for both toxicology and drug discovery applications, announced today that it has appointed biotechnology entrepreneur, scientist and engineer Robert S. Langer, Ph.D., to its …
TARA Biosystems Raises Seed Funding
January 5, 2016
News
January 5, 2016. NEW YORK, (Global Newswire) - TARA Biosystems, Inc., which provides physiologically-relevant “heart-on-a-chip” tissue models for both toxicology and drug discovery applications, raised $2.25 million in a seed financing to build commercial operations in New York City. Based on research from the laboratories of Columbia University Professor Gordana Vunjak-Novakovic and University …